Paclitaxel in Treating Older Patients With Solid Tumors

You may be eligible if

• DISEASE CHARACTERISTICS:
• Histologically proven nonhematologic malignancy
• PATIENT CHARACTERISTICS:
• Age:
• 55 and over
• Performance status:
• Zubrod 0-2
• Life expectancy:
• Not specified
• Hematopoietic:
• Granulocyte count at least 1,500/mm3
• Platelet count at least 100,000/mm3
• Hepatic:
• Bilirubin less than 1.5 mg/dL
• SGOT less than 2.0 times upper limit of normal (ULN)
• Renal:
• Creatinine no greater than 1.5 times ULN
• Cardiovascular:
• No uncontrolled or severe cardiovascular disease
• Other:
• No serious intercurrent medical illnesses that in the judgement of the investigator compromise patient care
• No psychiatric conditions that would preclude study
• No requirement for antibiotics for active acute infection
• PRIOR CONCURRENT THERAPY:
• Biologic therapy:
• Not specified
• Chemotherapy:
• At least 4 weeks since prior chemotherapy (6 weeks for nitrosoureas or mitomycin)
• No more than one prior chemotherapy regimen allowed
• No prior paclitaxel allowed
• Endocrine therapy:
• Not specified
• Radiotherapy:
• At least 4 weeks since prior radiation therapy
• Surgery:
• Not specified